Adjuvant trastuzumab for HER2-positive breast cancer Journal Articles

authors

• Spicer, James
• Harries, Mark
• Ellis, Peter

status

• published 

publication date

• August 2005

has subject area

• 11 Medical and Health Sciences (FoR)
• Antibodies, Monoclonal (MeSH)
• Antibodies, Monoclonal, Humanized (MeSH)
• Breast Neoplasms (MeSH)
• Chemotherapy, Adjuvant (MeSH)
• Female (MeSH)
• General & Internal Medicine (Science Metrix)
• Humans (MeSH)
• Receptor, ErbB-2 (MeSH)
• Trastuzumab (MeSH)

published in

• The Lancet  Journal

keywords

• Antibodies, Monoclonal
• Antibodies, Monoclonal, Humanized
• Breast Neoplasms
• Chemotherapy, Adjuvant
• Female
• Humans
• Receptor, ErbB-2
• Trastuzumab

Digital Object Identifier (DOI)

• 10.1016/s0140-6736(05)67134-6

PubMed ID

• 16112298

start page

• 634

end page

• 634

volume

• 366

issue

• 9486